FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to compounds of the formula [I]: wherein radical values are given in the description, or to its pharmaceutically acceptable salt. Compound of the formula [I] of the invention and its pharmaceutically acceptable salt are useful in prophylactic and/or therapeutic treatment of pollakiuria or enuresis. The aim of the invention involves preparing pharmaceutical compositions possessing agonistic activity with respect to β3-adrenoceptors and comprising compound of the formula [I] as an active component, or its pharmaceutically acceptable salt for administration in human body or animal as prophylactic and/or therapeutic treatment of pollakiuria or enuresis.
EFFECT: valuable medicinal properties of compound and pharmaceutical composition.
10 cl, 73 ex
Title | Year | Author | Number |
---|---|---|---|
CASR ANTAGONIST | 2004 |
|
RU2315036C2 |
AMINO ALCOHOL DERIVATIVES | 2005 |
|
RU2399614C2 |
PROLYL HYDROXYLASE INHIBITORS AND APPLICATION METHODS THEREOF | 2007 |
|
RU2429226C9 |
4-OXOQUINOLINE COMPOUND AND ITS USING AS HIV INTEGRASE INHIBITOR | 2003 |
|
RU2275361C2 |
NEW PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AND APPLICATION THEREOF | 2014 |
|
RU2621709C2 |
PYRAZOLE DERIVATIVES | 2004 |
|
RU2332412C2 |
BENZOXAZEPINE PI3K INHIBITORS AND METHODS OF USE | 2010 |
|
RU2600927C2 |
VLA-4 INHIBITORS | 2001 |
|
RU2290403C2 |
DIAMINE DERIVATIVES | 2003 |
|
RU2333203C2 |
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
Authors
Dates
2008-03-20—Published
2003-06-25—Filed